Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 168625
Corporate User License Price USD 7500
Corporate User License Price INR 505875
Site License Price USD 5000
Site License Price INR 337250
Request a Quote

Report Title

Psoriasis-Pipeline Review, H1 2017

Quote Request for License Type
License Type Price  
Single User License USD 2500
Site License USD 5000
Enterprise Wide License USD 7500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Psoriasis-Pipeline Review, H1 2017


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Psoriasis-Pipeline Review, H1 2017

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Psoriasis-Pipeline Review, H1 2017



Executive Summary

Psoriasis-Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis-Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape.

Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up skin, itchiness, and burning sensation, swollen and stiff joints. Predisposing factors include heredity, side effects of certain medicines, stress, infections and environmental conditions. The condition may be controlled by topical or systemic medications and phototherapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Psoriasis-Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Psoriasis (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Psoriasis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Psoriasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 14, 1, 21, 44, 42, 1, 103, 32 and 9 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 8 and 6 molecules, respectively.

Psoriasis (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Psoriasis (Immunology).

The pipeline guide reviews pipeline therapeutics for Psoriasis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Psoriasis (Immunology) therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Psoriasis (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Psoriasis (Immunology)

Reasons to buy

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Psoriasis (Immunology).

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Psoriasis (Immunology) pipeline depth and focus of Indication therapeutics.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents 2

Introduction 8

Psoriasis-Overview 9

Psoriasis-Therapeutics Development 10

Psoriasis-Therapeutics Assessment 39

Psoriasis-Companies Involved in Therapeutics Development 55

Psoriasis-Drug Profiles 130

Psoriasis-Discontinued Products 607

Psoriasis-Product Development Milestones 610

Appendix 619

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Number of Products under Development for Acromegaly, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products by Targets, H1 2017

Number of Products by Stage and Targets, H1 2017

Number of Products by Top 10 Mechanism of Actions, H1 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017

Number of Products by Routes of Administration, H1 2017

Number of Products by Stage and Routes of Administration, H1 2017

Number of Products by Molecule Types, H1 2017

Number of Products by Stage and Molecule Types, H1 2017

List of Tables

Number of Products under Development for Psoriasis, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..5), H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..6), H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..7), H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..8), H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..9), H1 2017

Number of Products under Development by Universities/Institutes, H1 2017

Products under Development by Companies, H1 2017

Products under Development by Companies, H1 2017 (Contd..1), H1 2017

Products under Development by Companies, H1 2017 (Contd..2), H1 2017

Products under Development by Companies, H1 2017 (Contd..3), H1 2017

Products under Development by Companies, H1 2017 (Contd..4), H1 2017

Products under Development by Companies, H1 2017 (Contd..5), H1 2017

Products under Development by Companies, H1 2017 (Contd..6), H1 2017

Products under Development by Companies, H1 2017 (Contd..7), H1 2017

Products under Development by Companies, H1 2017 (Contd..8), H1 2017

Products under Development by Companies, H1 2017 (Contd..9), H1 2017

Products under Development by Companies, H1 2017 (Contd..10), H1 2017

Products under Development by Companies, H1 2017 (Contd..11), H1 2017

Products under Development by Companies, H1 2017 (Contd..12), H1 2017

Products under Development by Companies, H1 2017 (Contd..13), H1 2017

Products under Development by Companies, H1 2017 (Contd..14), H1 2017

Products under Development by Universities/Institutes, H1 2017

Number of Products by Stage and Target, H1 2017

Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017

Number of Products by Stage and Target, H1 2017 (Contd..2), H1 2017

Number of Products by Stage and Target, H1 2017 (Contd..3), H1 2017

Number of Products by Stage and Target, H1 2017 (Contd..4), H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..2), H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..3), H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..4), H1 2017

Number of Products by Stage and Route of Administration, H1 2017

Number of Products by Stage and Molecule Type, H1 2017

Psoriasis-Pipeline by 3SBio Inc, H1 2017

Psoriasis-Pipeline by AbbVie Inc, H1 2017

Psoriasis-Pipeline by Abeome Corp, H1 2017

Psoriasis-Pipeline by AbGenomics International Inc, H1 2017

Psoriasis-Pipeline by Addex Therapeutics Ltd, H1 2017

Psoriasis-Pipeline by Adello Biologics LLC, H1 2017

Psoriasis-Pipeline by Advinus Therapeutics Ltd, H1 2017

Psoriasis-Pipeline by Affibody AB, H1 2017

Psoriasis-Pipeline by Albireo Pharma Inc, H1 2017

Psoriasis-Pipeline by Alfacyte Ltd, H1 2017

Psoriasis-Pipeline by Allergan Plc, H1 2017

Psoriasis-Pipeline by Almirall SA, H1 2017

Psoriasis-Pipeline by Alteogen Inc, H1 2017

Psoriasis-Pipeline by Alvotech Iceland, H1 2017

Psoriasis-Pipeline by Amgen Inc, H1 2017

Psoriasis-Pipeline by Anacor Pharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by AnaptysBio Inc, H1 2017

Psoriasis-Pipeline by ApoPharma Inc, H1 2017

Psoriasis-Pipeline by Arbor Pharmaceuticals LLC, H1 2017

Psoriasis-Pipeline by Arena Pharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by Argos Therapeutics Inc, H1 2017

Psoriasis-Pipeline by Arrien Pharmaceuticals LLC, H1 2017

Psoriasis-Pipeline by AstraZeneca Plc, H1 2017

Psoriasis-Pipeline by Athenex Inc, H1 2017

Psoriasis-Pipeline by Atlantic Bio Sci LLC, H1 2017

Psoriasis-Pipeline by Aurigene Discovery Technologies Ltd, H1 2017

Psoriasis-Pipeline by Aurinia Pharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by Bayer AG, H1 2017

Psoriasis-Pipeline by Beta Pharma Inc, H1 2017

Psoriasis-Pipeline by BioApex sro, H1 2017

Psoriasis-Pipeline by Biocad, H1 2017

Psoriasis-Pipeline by Biocon Ltd, H1 2017

Psoriasis-Pipeline by BioLingus AG, H1 2017

Psoriasis-Pipeline by BioMAS Ltd, H1 2017

Psoriasis-Pipeline by Biomics Biotechnologies Co Ltd, H1 2017

Psoriasis-Pipeline by Bionomics Ltd, H1 2017

Psoriasis-Pipeline by Bionovis SA, H1 2017

Psoriasis-Pipeline by BirchBioMed Inc, H1 2017

Psoriasis-Pipeline by Boehringer Ingelheim GmbH, H1 2017

Psoriasis-Pipeline by Brickell Biotech Inc, H1 2017

Psoriasis-Pipeline by Bristol-Myers Squibb Company, H1 2017

Psoriasis-Pipeline by C4X Discovery Holdings PLC, H1 2017

Psoriasis-Pipeline by CalciMedica Inc, H1 2017

Psoriasis-Pipeline by Can-Fite BioPharma Ltd, H1 2017

Psoriasis-Pipeline by Celgene Corp, H1 2017

Psoriasis-Pipeline by Cell Medica Ltd, H1 2017

Psoriasis-Pipeline by Cellceutix Corp, H1 2017

Psoriasis-Pipeline by ChemoCentryx Inc, H1 2017

Psoriasis-Pipeline by Chipscreen Biosciences Ltd, H1 2017

Psoriasis-Pipeline by ChironWells GmbH, H1 2017

Psoriasis-Pipeline by Coherus BioSciences Inc, H1 2017

Psoriasis-Pipeline by Compugen Ltd, H1 2017

Psoriasis-Pipeline by Concenter BioPharma Silkim Ltd, H1 2017

Psoriasis-Pipeline by Crescita Therapeutics Inc, H1 2017

Psoriasis-Pipeline by CritiTech Inc, H1 2017

Psoriasis-Pipeline by Curapel Ltd, H1 2017

Psoriasis-Pipeline by Dermala Inc, H1 2017

Psoriasis-Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittle, H1 2017

Psoriasis-Pipeline by DURECT Corp, H1 2017

Psoriasis-Pipeline by EA Pharma Co Ltd, H1 2017

Psoriasis-Pipeline by Eli Lilly and Company, H1 2017

Psoriasis-Pipeline by ELORAC Inc, H1 2017

Psoriasis-Pipeline by Exicure Inc, H1 2017

Psoriasis-Pipeline by Foamix Pharmaceuticals Ltd, H1 2017

Psoriasis-Pipeline by Forward Pharma A/S, H1 2017

Psoriasis-Pipeline by Galapagos NV, H1 2017

Psoriasis-Pipeline by Galderma SA, H1 2017

Psoriasis-Pipeline by Galectin Therapeutics Inc, H1 2017

Psoriasis-Pipeline by Gem Pharmaceuticals LLC, H1 2017

Psoriasis-Pipeline by Genentech Inc, H1 2017

Psoriasis-Pipeline by Genor BioPharma Co Ltd, H1 2017

Psoriasis-Pipeline by GlaxoSmithKline Plc, H1 2017

Psoriasis-Pipeline by GlycoMar Ltd, H1 2017

Psoriasis-Pipeline by Grupo Ferrer Internacional SA, H1 2017

Psoriasis-Pipeline by HitGen LTD, H1 2017

Psoriasis-Pipeline by Huabo Biopharm Co Ltd, H1 2017

Psoriasis-Pipeline by Hydra Biosciences Inc, H1 2017

Psoriasis-Pipeline by iCo Therapeutics Inc., H1 2017

Psoriasis-Pipeline by Immune Pharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by Immune Response BioPharma Inc, H1 2017

Psoriasis-Pipeline by Immungenetics AG, H1 2017

Psoriasis-Pipeline by Immunwork Inc, H1 2017

Psoriasis-Pipeline by Japan Tobacco Inc, H1 2017

Psoriasis-Pipeline by Jenrin Discovery Inc, H1 2017

Psoriasis-Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2017

Psoriasis-Pipeline by Johnson & Johnson, H1 2017

Psoriasis-Pipeline by Kadmon Corp LLC, H1 2017

Psoriasis-Pipeline by KaloBios Pharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by Kang Stem Biotech Co Ltd, H1 2017

Psoriasis-Pipeline by KPI Therapeutics Inc, H1 2017

Psoriasis-Pipeline by Lead Pharma Holding BV, H1 2017

Psoriasis-Pipeline by LEO Pharma A/S, H1 2017

Psoriasis-Pipeline by Lupin Ltd, H1 2017

Psoriasis-Pipeline by Lycera Corp, H1 2017

Psoriasis-Pipeline by mAbxience SA, H1 2017

Psoriasis-Pipeline by Maruho Co Ltd, H1 2017

Psoriasis-Pipeline by Medestea Research & Production SpA, H1 2017

Psoriasis-Pipeline by MediGene AG, H1 2017

Psoriasis-Pipeline by Merck KGaA, H1 2017

Psoriasis-Pipeline by MetrioPharm AG, H1 2017

Psoriasis-Pipeline by Mitsubishi Tanabe Pharma Corp, H1 2017

Psoriasis-Pipeline by Momenta Pharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by Mycenax Biotech Inc, H1 2017

Psoriasis-Pipeline by Nimbus Therapeutics LLC, H1 2017

Psoriasis-Pipeline by NovaLead Pharma Pvt Ltd, H1 2017

Psoriasis-Pipeline by Novan Inc, H1 2017

Psoriasis-Pipeline by Novartis AG, H1 2017

Psoriasis-Pipeline by Nuevolution AB, H1 2017

Psoriasis-Pipeline by Numab Innovation AG, H1 2017

Psoriasis-Pipeline by Oncobiologics Inc, H1 2017

Psoriasis-Pipeline by OSE Immunotherapeutics, H1 2017

Psoriasis-Pipeline by Panacea Biotec Ltd, H1 2017

Psoriasis-Pipeline by Pfizer Inc, H1 2017

Psoriasis-Pipeline by Pharis Biotec GmbH, H1 2017

Psoriasis-Pipeline by Pharmedartis GmbH, H1 2017

Psoriasis-Pipeline by Philogen SpA, H1 2017

Psoriasis-Pipeline by PinCell srl, H1 2017

Psoriasis-Pipeline by Principia Biopharma Inc, H1 2017

Psoriasis-Pipeline by Promius Pharma LLC, H1 2017

Psoriasis-Pipeline by Protalix BioTherapeutics Inc, H1 2017

Psoriasis-Pipeline by Prothena Corp Plc, H1 2017

Psoriasis-Pipeline by Provectus Biopharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by Qilu Pharmaceutical Co Ltd, H1 2017

Psoriasis-Pipeline by RedHill Biopharma Ltd, H1 2017

Psoriasis-Pipeline by Reliance Life Sciences Pvt Ltd, H1 2017

Psoriasis-Pipeline by Rigel Pharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by Rock Creek Pharmaceuticals, Inc., H1 2017

Psoriasis-Pipeline by Samumed LLC, H1 2017

Psoriasis-Pipeline by Sandoz International GmbH, H1 2017

Psoriasis-Pipeline by Sareum Holdings Plc, H1 2017

Psoriasis-Pipeline by SBI Biotech Co Ltd, H1 2017

Psoriasis-Pipeline by Shulov Innovative Science Ltd, H1 2017

Psoriasis-Pipeline by Sigmoid Pharma Ltd, H1 2017

Psoriasis-Pipeline by Soligenix Inc, H1 2017

Psoriasis-Pipeline by Spherium Biomed SL, H1 2017

Psoriasis-Pipeline by sterna biologicals Gmbh & Co KG, H1 2017

Psoriasis-Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2017

Psoriasis-Pipeline by SWITCH Biotech LLC, H1 2017

Psoriasis-Pipeline by Syntrix Biosystems Inc, H1 2017

Psoriasis-Pipeline by Takeda Pharmaceutical Company Ltd, H1 2017

Psoriasis-Pipeline by Tasly Pharmaceutical Group Co Ltd, H1 2017

Psoriasis-Pipeline by Teva Pharmaceutical Industries Ltd, H1 2017

Psoriasis-Pipeline by TheraMAB LLC, H1 2017

Psoriasis-Pipeline by Tolero Pharmaceuticals Inc, H1 2017

Psoriasis-Pipeline by UCB SA, H1 2017

Psoriasis-Pipeline by Valeant Pharmaceuticals International Inc, H1 2017

Psoriasis-Pipeline by vTv Therapeutics Inc, H1 2017

Psoriasis-Pipeline by Wellstat Therapeutics Corp, H1 2017

Psoriasis-Pipeline by XBiotech Inc, H1 2017

Psoriasis-Pipeline by Yuhan Corp, H1 2017

Psoriasis-Dormant Projects, H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..1), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..2), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..3), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..4), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..5), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..6), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..7), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..8), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..9), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..10), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..11), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..12), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..13), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..14), H1 2017

Psoriasis-Dormant Projects, H1 2017 (Contd..15), H1 2017

Psoriasis-Discontinued Products, H1 2017

Psoriasis-Discontinued Products, H1 2017 (Contd..1), H1 2017

Psoriasis-Discontinued Products, H1 2017 (Contd..2), H1 2017

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

3SBio Inc, AbbVie Inc, Abeome Corp, AbGenomics International Inc, Addex Therapeutics Ltd, Adello Biologics LLC, Advinus Therapeutics Ltd, Affibody AB, Albireo Pharma Inc, Alfacyte Ltd, Allergan Plc, Almirall SA, Alteogen Inc, Alvotech Iceland, Amgen Inc, Anacor Pharmaceuticals Inc, AnaptysBio Inc, ApoPharma Inc, Arbor Pharmaceuticals LLC, Arena Pharmaceuticals Inc, Argos Therapeutics Inc, Arrien Pharmaceuticals LLC, AstraZeneca Plc, Athenex Inc, Atlantic Bio Sci LLC, Aurigene Discovery Technologies Ltd, Aurinia Pharmaceuticals Inc, Bayer AG, Beta Pharma Inc, BioApex sro, Biocad, Biocon Ltd, BioLingus AG, BioMAS Ltd, Biomics Biotechnologies Co Ltd, Bionomics Ltd, Bionovis SA, BirchBioMed Inc, Boehringer Ingelheim GmbH, Brickell Biotech Inc, Bristol-Myers Squibb Company, C4X Discovery Holdings PLC, CalciMedica Inc, Can-Fite BioPharma Ltd, Celgene Corp, Cell Medica Ltd, Cellceutix Corp, ChemoCentryx Inc, Chipscreen Biosciences Ltd, ChironWells GmbH, Coherus BioSciences Inc, Compugen Ltd, Concenter BioPharma Silkim Ltd, Crescita Therapeutics Inc, CritiTech Inc, Curapel Ltd, Dermala Inc, Dr. August Wolff GmbH & Co KG Arzneimittle, DURECT Corp, EA Pharma Co Ltd, Eli Lilly and Company, ELORAC Inc, Exicure Inc, Foamix Pharmaceuticals Ltd, Forward Pharma A/S, Galapagos NV, Galderma SA, Galectin Therapeutics Inc, Gem Pharmaceuticals LLC, Genentech Inc, Genor BioPharma Co Ltd, GlaxoSmithKline Plc, GlycoMar Ltd, Grupo Ferrer Internacional SA, HitGen LTD, Huabo Biopharm Co Ltd, Hydra Biosciences Inc, iCo Therapeutics Inc., Immune Pharmaceuticals Inc, Immune Response BioPharma Inc, Immungenetics AG, Immunwork Inc, Japan Tobacco Inc, Jenrin Discovery Inc, Jiangsu Hengrui Medicine Co Ltd, Johnson & Johnson, Kadmon Corp LLC, KaloBios Pharmaceuticals Inc, Kang Stem Biotech Co Ltd, KPI Therapeutics Inc, Lead Pharma Holding BV, LEO Pharma A/S, Lupin Ltd, Lycera Corp, mAbxience SA, Maruho Co Ltd, Medestea Research & Production SpA, MediGene AG, Merck KGaA, MetrioPharm AG, Mitsubishi Tanabe Pharma Corp, Momenta Pharmaceuticals Inc, Mycenax Biotech Inc, Nimbus Therapeutics LLC, NovaLead Pharma Pvt Ltd, Novan Inc, Novartis AG, Nuevolution AB, Numab Innovation AG, Oncobiologics Inc, OSE Immunotherapeutics, Panacea Biotec Ltd, Pfizer Inc, Pharis Biotec GmbH, Pharmedartis GmbH, Philogen SpA, PinCell srl, Principia Biopharma Inc, Promius Pharma LLC, Protalix BioTherapeutics Inc, Prothena Corp Plc, Provectus Biopharmaceuticals Inc, Qilu Pharmaceutical Co Ltd, RedHill Biopharma Ltd, Reliance Life Sciences Pvt Ltd, Rigel Pharmaceuticals Inc, Rock Creek Pharmaceuticals, Inc., Samumed LLC, Sandoz International GmbH, Sareum Holdings Plc, SBI Biotech Co Ltd, Shulov Innovative Science Ltd, Sigmoid Pharma Ltd, Soligenix Inc, Spherium Biomed SL, sterna biologicals Gmbh & Co KG, Sun Pharma Advanced Research Company Ltd, SWITCH Biotech LLC, Syntrix Biosystems Inc, Takeda Pharmaceutical Company Ltd, Tasly Pharmaceutical Group Co Ltd, Teva Pharmaceutical Industries Ltd, TheraMAB LLC, Tolero Pharmaceuticals Inc, UCB SA, Valeant Pharmaceuticals International Inc, vTv Therapeutics Inc, Wellstat Therapeutics Corp, XBiotech Inc, Yuhan Corp


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand